Dewei Peng
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
-
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Inflammasome and immune disorders 3
-
- Atrial Fibrillation Management and Outcomes 5
- Cardiac electrophysiology and arrhythmias 3
- Cardiac Fibrosis and Remodeling 3
- Cardiac Arrhythmias and Treatments 2
- Cardiovascular Function and Risk Factors 2
- Co-authors
- Jiagao Lv (10 shared papers)Tao Jiang (7 shared papers)Lintong Men (10 shared papers)Shengqi Huo (9 shared papers)Li Lin (6 shared papers)Lulu Peng (7 shared papers)Junyi Guo (7 shared papers)Bingyu Huang (1 shared paper)
- Journals
- Free Radical Biology and Medicine (2 papers)Archives of Pharmacal Research (1 paper)European Journal of Pharmacology (1 paper)Molecular Medicine (1 paper)Cardiology Research and Practice (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Dewei Peng
19 papers receiving 294 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 50
- Pharmacology 28
- Pulmonary and Respiratory Medicine 84
- Cardiology and Cardiovascular Medicine 50
- Molecular Biology 143
Countries citing papers authored by Dewei Peng
This map shows the geographic impact of Dewei Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dewei Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dewei Peng more than expected).
Fields of papers citing papers by Dewei Peng
This network shows the impact of papers produced by Dewei Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dewei Peng. The network helps show where Dewei Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Dewei Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 84 | |
| 2 | 2017 | 44 | |
| 3 | 2022 | 37 | |
| 4 | 2021 | 25 | |
| 5 | 2022 | 23 | |
| 6 | 2022 | 22 | |
| 7 | 2019 | 19 | |
| 8 | 2023 | 14 | |
| 9 | 2022 | 5 | |
| 10 | 2023 | 4 | |
| 11 | 2024 | 3 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 3 | |
| 14 | 2020 | 2 | |
| 15 | 2025 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2025 | 0 |
About Dewei Peng
Dewei Peng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Nephrology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 295 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (5 papers), Cardiac electrophysiology and arrhythmias (3 papers), Inflammasome and immune disorders (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Cardiac Arrhythmias and Treatments (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Cardiovascular Function and Risk Factors (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Cancer Research (50 citations), Pharmacology (28 citations), Pulmonary and Respiratory Medicine (84 citations), Cardiology and Cardiovascular Medicine (50 citations) and Molecular Biology (143 citations). Dewei Peng has collaborated with scholars based in China and United States. Frequent co-authors include Jiagao Lv, Tao Jiang, Lintong Men, Shengqi Huo, Li Lin, Lulu Peng, Junyi Guo, Bingyu Huang, Mengying Zhu and Yue Jiang. Their work appears in journals such as Free Radical Biology and Medicine, Archives of Pharmacal Research, European Journal of Pharmacology, Molecular Medicine and Cardiology Research and Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.